British billionaire charged with insider trading in biotech companies

Hedge fund owner Joe Lewis has been accused of misusing insider information from Solid Biosciences and Mirati Therapeutics.
Joe Lewis (right) pleads not guilty to insider trading charges. | Photo: Angela Weiss
Joe Lewis (right) pleads not guilty to insider trading charges. | Photo: Angela Weiss

The US Securities and Exchange Commission (SEC) filed charges against British billionaire Joe Lewis last week. He is the owner and founder of the Tavistock Group and has a controlling stake in the London-based football team Tottenham Hotspur.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading